589
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Posterior Blepharitis and Associated Potential Factors: A Study among Pregnant Women

, OD, PhD, , ODORCID Icon, , PhD & , MBChB, MGCPS
Pages 1475-1481 | Received 27 Sep 2020, Accepted 22 Feb 2021, Published online: 08 Mar 2021

References

  • Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf. 2009;7:S1–S14. doi:10.1016/S1542-0124(12)70620-1.
  • Putnam CM. Diagnosis and management of blepharitis: an optometrist’s perspective. Clin Optometry. 2016;8:71. doi:10.2147/OPTO.S84795.
  • Chiang -C-C, Lin C-L, Tsai -Y-Y, Cl P, Yt L, Fc S. Patients with blepharitis are at elevated risk of anxiety and depression. PloS One. 2013;8:e83335–e83335. doi:10.1371/journal.pone.0083335.
  • Nelson JD, Shimazaki J, Benitez-del-castillo JM, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52:1930–1937. doi:10.1167/iovs.10-6997b.
  • Amescua G, Akpek EK, Farid M, et al. Blepharitis preferred practice pattern®. Ophthalmology. 2019;126:56–93. doi:10.1016/j.ophtha.2018.10.019.
  • Yildiz E, Yenerel NM, Turan-Yardimci A, Erkan M, Gunes P. Comparison of the clinical efficacy of topical and systemic azithromycin treatment for posterior blepharitis. J Ocul Pharmacol Ther. 2018;34:365–372. doi:10.1089/jop.2017.0095.
  • Yun ST, Woo DM, Chong CW, et al. Utilisation of a novel test to measure severity and treatment efficacy of posterior blepharitis. J Ophthalmol. 2015;617019:2015.
  • Nemet AY, Vinker S, Kaiserman I. Associated morbidity of blepharitis. Ophthalmology. 2011;118:1062–1068. doi:10.1016/j.ophtha.2010.10.015.
  • Homko CJ, Sivan E, Reece EA, Boden G. Fuel metabolism during pregnancy. Semin Reprod Endocrinol. 1999;17(2):119–125. doi:10.1055/s-2007-1016219
  • Parchwani D, Patel D. Status of lipid profile in pregnancy. J Med Res. 2011;1:10–12.
  • Asiedu K, Kyei S, Mensah SN, Ocansey S, Abu LS, Kyere EA. Ocular surface disease index (OSDI) versus the standard patient evaluation of eye dryness (SPEED): a study of a nonclinical sample. Cornea. 2016;35:175–180. doi:10.1097/ICO.0000000000000712.
  • Asiedu K. Rasch analysis of the standard patient evaluation of eye dryness questionnaire. Eye Contact Lens. 2017;43:394–398. doi:10.1097/ICL.0000000000000288.
  • Ngo W, Situ P, Keir N, Korb D, Blackie C, Simpson T. Psychometric properties and validation of the standard patient evaluation of eye dryness questionnaire. Cornea. 2013;32:1204–1210. doi:10.1097/ICO.0b013e318294b0c0.
  • Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52:2006–2049.
  • Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640–650. doi:10.1097/00003226-200310000-00008.
  • Arita R, Minoura I, Morishige N, et al. Development of definitive and reliable grading scales for meibomian gland dysfunction. Am J Ophthalmol. 2016;169:125–137. doi:10.1016/j.ajo.2016.06.025.
  • Feitosa ACR, Barreto LT, Silva I, Silva FFD, Feitosa GS. Impact of the use of different diagnostic criteria in the prevalence of dyslipidemia in pregnant women. Arq Bras Cardiol. 2017;109:30–38. doi:10.5935/abc.20170070.
  • Piechota W, Staszewski A. Reference ranges of lipids and apolipoproteins in pregnancy. Eur J Obstet Gynecol Reprod Biol. 1992;45:27–35. doi:10.1016/0028-2243(92)90190-A.
  • Knopp RH, Bergelin RO, Wahl PW, Walden CE, Chapman M, Irvine S. Population-based lipoprotein lipid reference values for pregnant women compared to nonpregnant women classified by sex hormone usage. Am J Obstet Gynecol. 1982;143:626–637. doi:10.1016/0002-9378(82)90107-7.
  • Rolando M, Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol. 2001;45:S203–S210. doi:10.1016/S0039-6257(00)00203-4.
  • Johnson ME, Murphy PJ. Changes in the tear film and ocular surface from dry eye syndrome. Prog Retin Eye Res. 2004;23:449–474.
  • Truong S, Cole N, Stapleton F, Golebiowski B. Sex hormones and the dry eye. Clin Exp Optometry. 2014;97:324–336.
  • Sullivan DA, Sullivan BD, Ullman MD, et al. Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci. 2000;41:3732–3742.
  • Suzuki T, Schirra F, Richards SM, Jensen RV, Sullivan DA. Estrogen and progesterone control of gene expression in the mouse meibomian gland. Invest Ophthalmol Vis Sci. 2008;49:1797–1808. doi:10.1167/iovs.07-1458.
  • Kyei S, Ephraim RKD, Animful S, et al. Impact of serum prolactin and testosterone levels on the clinical parameters of dry eye in pregnant women. J Ophthalmol. 2020;1491602:2020.
  • Golebiowski B, Badarudin N, Eden J, You J, Hampel U, Stapleton F. Does endogenous serum oestrogen play a role in meibomian gland dysfunction in postmenopausal women with dry eye? Br J Ophthalmol. 2017;101:218–222. doi:10.1136/bjophthalmol-2016-308473.
  • Lee C-Y, Chen H-C, Lin H-W, et al. Blepharitis as an early sign of metabolic syndrome: a nationwide population-based study. British J Ophthalmol. 2018;102:1283. doi:10.1136/bjophthalmol-2017-310975.
  • Braich PS, Howard MK, Singh JS. Dyslipidemia and its association with meibomian gland dysfunction. Int Ophthalmol. 2016;36:469–476. doi:10.1007/s10792-015-0149-4.
  • Guliani BP, Bhalla A, Naik MP. Association of the severity of meibomian gland dysfunction with dyslipidemia in Indian population. Indian J Ophthalmol. 2018;66:1411–1416. doi:10.4103/ijo.IJO_1256_17.
  • Dao AH, Spindle JD, Harp BA, Jacob A, Chuang AZ, Yee RW. Association of dyslipidemia in moderate to severe meibomian gland dysfunction. Am J Ophthalmol. 2010;150:371–375.e371.
  • Pinna A, Blasetti F, Zinellu A, Carru C, Solinas G. Meibomian gland dysfunction and hypercholesterolemia. Ophthalmology. 2013;120:2385–2389. doi:10.1016/j.ophtha.2013.05.002.
  • Kuriakose RK, Braich PS. Dyslipidemia and its association with meibomian gland dysfunction: a systematic review. Int Ophthalmol. 2018;38:1809–1816. doi:10.1007/s10792-017-0633-0.
  • Liu S, Dong H, Huang X, Tang SH. Analysis of factors leading to lid wiper epitheliopathy. Eur Rev Med Pharmacol Sci. 2020;24:1593–1601.
  • Knop N, Korb DR, Blackie CA, Knop E. The lid wiper contains goblet cells and goblet cell crypts for ocular surface lubrication during the blink. Cornea. 2012;31:668–679. doi:10.1097/ICO.0b013e31823f8d8c.
  • Knop E, Knop N, Zhivov A, et al. The lid wiper and muco-cutaneous junction anatomy of the human eyelid margins: an in vivo confocal and histological study. J Anat. 2011;218:449–461. doi:10.1111/j.1469-7580.2011.01355.x.
  • Viso E, Rodríguez-Ares MT, Abelenda D, Oubina B, Gude F. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci. 2012;53:2601–2606.
  • Asiedu K, Kyei S, Dzasimatu SK, Morny EK. Meibomian gland dysfunction in a youthful clinical sample in Ghana. Optom Vis Sci. 2018;95:349–353. doi:10.1097/OPX.0000000000001192.
  • Asiedu K, Dzasimatu SK, Kyei S. Clinical subtypes of dry eye in youthful clinical sample in Ghana. Cont Lens Anterior Eye. 2019;42:206–211. doi:10.1016/j.clae.2018.10.005.
  • Amano S, Inoue K. Estimation of prevalence of meibomian gland dysfunction in Japan. Cornea. 2017;36:684–688. doi:10.1097/ICO.0000000000001208.
  • Amano S, Inoue K. Clinic-based study on meibomian gland dysfunction in Japan. Invest Ophthalmol Vis Sci. 2017;58:1283–1287. doi:10.1167/iovs.16-21374.
  • Korb DR, Blackie CA. “Dry eye” is the wrong diagnosis for millions. Optom Vis Sci. 2015;92:e350–354. doi:10.1097/OPX.0000000000000676.
  • Arita R, Fukuoka S. Efficacy of azithromycin eyedrops for individuals with meibomian gland dysfunction–associated posterior blepharitis. Eye Contact Lens. 2021;47:54. doi:10.1097/ICL.0000000000000729.
  • Nichols KK, Foulks GN, Bron AJ, et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci. 2011;52:1922–1929. doi:10.1167/iovs.10-6997a.
  • Asiedu K, Kyei S, Ayobi B, Agyemang FO, Ablordeppey RK. Survey of eye practitioners’ preference of diagnostic tests and treatment modalities for dry eye in Ghana. Cont Lens Anterior Eye. 2016;39:411–415. doi:10.1016/j.clae.2016.08.001.
  • Nkiru ZN, Stella O, Udeh N, et al. Dry eye disease: a longitudinal study among pregnant women in Enugu, south east, Nigeria. Ocul Surf. 2019;17:458–463. doi:10.1016/j.jtos.2019.05.001.
  • Liu R, Rong B, Tu P, et al. Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction. Am J Ophthalmol. 2017;183:81–90. doi:10.1016/j.ajo.2017.08.021.
  • Geerling G, Tauber J, Baudouin C, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52:2050–2064. doi:10.1167/iovs.10-6997g.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.